Belgium
Aphea.Bio, founded in 2017 and headquartered in Belgium, stands at the forefront of biotechnological innovation in agriculture. The company, a proud member of the B Corp community, is dedicated to "Driving the Revolution in Biologicals," as outlined in their slogan.
Their mission focuses on transforming agriculture by leveraging microorganisms to develop biocontrol and biostimulant products. Through their APEXbioTM R&D platform, Aphea.Bio blends cutting-edge science with traditional knowledge to offer sustainable alternatives to chemical pesticides and synthetic fertilizers.
Recently, the company raised a substantial €70.00M Series C investment on 11 July 2023, demonstrating strong investor confidence. Key investors include Astanor Ventures, the Bill & Melinda Gates Foundation, BNP Paribas Fortis, and several others.
By collaborating globally with academic institutions, industry partners, and farmers, Aphea.Bio is well-positioned to advance sustainable agricultural practices, enhancing productivity while reducing the ecological footprint. This positions them as a compelling opportunity for investors seeking to make an impact in agriculture and biotechnology.
Verna
reNature